DJIA 17,841.98 -86.22 -0.48%
NASDAQ 4,919.64 -19.68 -0.40%
S&P 500 2,080.15 -9.31 -0.45%
market minute promo

9.14 -0.07 (-0.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACHN $9.14 -0.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.29
Previous Close $9.21
Daily Range $9.09 - $9.45
52-Week Range $2.45 - $16.87
Market Cap $1.1B
P/E Ratio -13.16
Dividend (Yield) $0.00 (0.0%)
Volume 2,520,144
Average Daily Volume 2,518,848
Current FY EPS -$0.96

Sector

Healthcare

Industry

Drug Makers

ACHILLION PHARMACEUTICALS, INC. (ACHN) Description

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/

News & Commentary

3 Biotech Stocks That Could Be Developing Billion Dollar Drugs

These three clinical stage biotech companies are working on therapies addressing billion dollar indications.

May 5 Premarket Briefing: 10 Things You Should Know

Next Week In Biotech: Earnings Deluge - From GSK And Achillion To Intercept And Vivus

Hepatitis C Competitive Landscape: The Holy Grail

Achillion Pharmaceuticals Could Hang With The HCV Big Boys

All You Need To Know About HCV From The EASL Conference This Weekend

Positioning For A Catalyst-Heavy 2015 In Achillion Pharmaceuticals

The Best Stock to Invest in Hep C

In the multibillion-dollar market for hepatitis C, this company stands above the crowd.

The Biotech Stocks JMP Is Watching

Gilead Experiencing Bumpy Ride Despite Strong Fundamentals

See More ACHN News...

ACHN's Top Competitors

ACHN $9.14 (-0.76%)
Current stock: ACHN
AMGN $158.96 (-0.30%)
Current stock: AMGN
CELG $108.65 (1.03%)
Current stock: CELG
GILD $102.27 (-0.70%)
Current stock: GILD